Invitation to presentation of BioArctic's first quarter report for January - March 2026 on May 20 at 9:30 a.m. CET

Rhea-AI Summary

BioArctic (NASDAQ Stockholm: BIOA B) will publish its first quarter 2026 report for January–March on May 20, 2026 at 8:00 a.m. CET. A webcast and teleconference in English with the CEO and CFO will follow at 9:30 a.m. CET, including a Q&A session.

The webcast requires online registration for written questions, while verbal questions are handled via a separate teleconference registration. A replay will be available on BioArctic's investor website after the presentation.

News Market Reaction – BIOA

+5.22%

+5.22% Session close to close

In the May 13 session, BIOA gained 5.22%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STOCKHOLM, May 13, 2026 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) will publish the company's first quarter report for January - March 2026 on Wednesday, May 20, 2026, at 8:00 a.m. CET.

In conjunction with the report, BioArctic invites investors, analysts and media to a webcast (in English) on May 20, at 9:30 a.m CET, where Gunilla Osswald, CEO, and Anders Martin-Löf, CFO, together with colleagues, will present and comment on the first quarter report, followed by a Q&A session.

If you wish to participate via the webcast, please use the link below, where you will be able to submit written questions.

Webcast: https://bioarctic.events.inderes.com/q1-report-2026/register

If you wish to ask questions verbally during the presentation, please participate via the teleconference and register using the link below. After registration, you will receive the phone numbers and a conference ID to access the call.

Teleconference: https://events.inderes.com/bioarctic/q1-report-2026/dial-in

The webcast will also be available on demand on BioArctic's corporate website after the presentation: https://www.bioarctic.com/en/investors/financial-reports-and-presentations/

For more information, please contact:
Anders Martin-Löf, CFO 
Phone: +46 70 683 79 77 
E-mail: Anders.martin-lof@bioarctic.com

Oskar Bosson
Phone: +46 704 107 180
E-mail: Oskar.Bosson@bioarctic.com

This information was submitted for publication at 08:30 a.m. CET on May 13, 2026.

About BioArctic AB

BioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company is the originator of Leqembi® (lecanemab) – the world's first drug proven to slow the progression of the disease and reduce cognitive impairment in early Alzheimer's disease. Leqembi has been developed together with Eisai. BioArctic has a broad research portfolio within Alzheimer's disease, Parkinson's disease, ALS and enzyme deficiency diseases. Several of the projects utilize the company's proprietary BrainTransporter™ technology, which improves the transport of drugs into the brain. BioArctic's B share (BIOA B) is listed on Nasdaq Stockholm Large Cap. For more information, please visit www.bioarctic.com.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/bioarctic/r/invitation-to-presentation-of-bioarctic-s-first-quarter-report-for-january---march-2026-on-may-20-at,c4347801

The following files are available for download:

https://mb.cision.com/Main/9978/4347801/4090284.pdf

​​​​​​​Invitation to presentation of BioArctic’s first quarter report for January â€" March 2026 on May 20 at 9:30 a.m. CET

 

View original content:https://www.prnewswire.com/news-releases/invitation-to-presentation-of-bioarctics-first-quarter-report-for-january--march-2026-on-may-20-at-930-am-cet-302770612.html

SOURCE BioArctic

FAQ

When will BioArctic (BIOA B) release its Q1 2026 report?

BioArctic plans to publish its Q1 2026 report on May 20, 2026 at 8:00 a.m. CET. According to BioArctic, the report will cover the period January to March 2026 and precede a webcast presentation.

What time is BioArctic's Q1 2026 results webcast on May 20, 2026?

The Q1 2026 webcast for BioArctic is scheduled for 9:30 a.m. CET on May 20, 2026. According to BioArctic, the CEO and CFO will present the report in English, followed by a Q&A session.

How can investors join the BioArctic (BIOA B) Q1 2026 earnings webcast?

Investors can join the BioArctic Q1 2026 webcast by registering via the provided webcast link. According to BioArctic, registration enables online participation and submission of written questions during the live presentation.

How do I ask verbal questions during BioArctic's Q1 2026 conference call?

To ask verbal questions, participants must register via the separate teleconference link. According to BioArctic, registration provides dial-in phone numbers and a conference ID needed to access the call and speak during the Q&A.

Will a replay of the BioArctic Q1 2026 webcast be available for investors?

Yes, a replay of the Q1 2026 webcast will be available on BioArctic's investor website. According to BioArctic, the on-demand version can be accessed under financial reports and presentations after the live event.

Who will present BioArctic's Q1 2026 results on May 20, 2026?

The Q1 2026 results will be presented by CEO Gunilla Osswald and CFO Anders Martin-Löf. According to BioArctic, they will be joined by colleagues to comment on the report and answer investor and analyst questions.